array(40) {
  [0]=>
  string(4) "5253"
  ["article_id"]=>
  string(4) "5253"
  [1]=>
  string(17) "euroPLX 71 Lisbon"
  ["article_title"]=>
  string(17) "euroPLX 71 Lisbon"
  [2]=>
  string(150) "The 71st euroPLX Pharma Partnering Conference will be held in Cascais, a picturesque town, located about 25-30 driving minutes from Lisbon. euroPLX 71"
  ["short_description"]=>
  string(150) "The 71st euroPLX Pharma Partnering Conference will be held in Cascais, a picturesque town, located about 25-30 driving minutes from Lisbon. euroPLX 71"
  [3]=>
  string(506) "The 71st euroPLX Pharma Partnering Conference will be held in Cascais, a picturesque town, located about 25-30 driving minutes from Lisbon. euroPLX 71 Lisbon is expected to see 350 to 400 top level business development executives from all over the world.&#nl&#nlThe online interaction and matchmaking systems of euroPLX Conferences provide 25 to 30 pre-arranged business meetings per attending company. It is the preferred partnering platform for new business opportunities since 24 years. Information e..."
  ["description"]=>
  string(506) "The 71st euroPLX Pharma Partnering Conference will be held in Cascais, a picturesque town, located about 25-30 driving minutes from Lisbon. euroPLX 71 Lisbon is expected to see 350 to 400 top level business development executives from all over the world.&#nl&#nlThe online interaction and matchmaking systems of euroPLX Conferences provide 25 to 30 pre-arranged business meetings per attending company. It is the preferred partnering platform for new business opportunities since 24 years. Information e..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(49) "https://www.pharmiweb.com/event/europlx-71-lisbon"
  ["blog_url"]=>
  string(49) "https://www.pharmiweb.com/event/europlx-71-lisbon"
  [15]=>
  string(19) "2019-01-15 19:48:34"
  ["add_date"]=>
  string(19) "2019-01-15 19:48:34"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:27"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1540"
  ["article_id"]=>
  string(4) "1540"
  [1]=>
  string(74) "MHRA confirms it will consider UK version of Falsified Medicines Directive"
  ["article_title"]=>
  string(74) "MHRA confirms it will consider UK version of Falsified Medicines Directive"
  [2]=>
  string(152) "With less than a month until the Falsified Medicines Directive is implemented on 9 February 2019, the Medicines and Healthcare products Regulatory Ag"
  ["short_description"]=>
  string(152) "With less than a month until the Falsified Medicines Directive is implemented on 9 February 2019, the Medicines and Healthcare products Regulatory Ag"
  [3]=>
  string(254) "With less than a month until the Falsified Medicines Directive is implemented on 9 February 2019, the Medicines and Healthcare products Regulatory Agency has confirmed that if there is a no-deal Brexit it will consider a UK-only version of the EU law."
  ["description"]=>
  string(254) "With less than a month until the Falsified Medicines Directive is implemented on 9 February 2019, the Medicines and Healthcare products Regulatory Agency has confirmed that if there is a no-deal Brexit it will consider a UK-only version of the EU law."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(162) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/mhra-confirms-it-will-consider-uk-version-of-falsified-medicines-directive/20206001.article"
  ["blog_url"]=>
  string(162) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/mhra-confirms-it-will-consider-uk-version-of-falsified-medicines-directive/20206001.article"
  [15]=>
  string(19) "2019-01-15 18:00:00"
  ["add_date"]=>
  string(19) "2019-01-15 18:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1569"
  ["article_id"]=>
  string(4) "1569"
  [1]=>
  string(48) "FDA Cites GlaxoSmithKline for Problems With SOPs"
  ["article_title"]=>
  string(48) "FDA Cites GlaxoSmithKline for Problems With SOPs"
  [2]=>
  string(144) "&#nl        The FDA cited GlaxoSmithKline’s East Durham, New York facility for failing to follow standard operating procedures.&#nl      "
  ["short_description"]=>
  string(144) "&#nl        The FDA cited GlaxoSmithKline’s East Durham, New York facility for failing to follow standard operating procedures.&#nl      "
  [3]=>
  string(144) "&#nl        The FDA cited GlaxoSmithKline’s East Durham, New York facility for failing to follow standard operating procedures.&#nl      "
  ["description"]=>
  string(144) "&#nl        The FDA cited GlaxoSmithKline’s East Durham, New York facility for failing to follow standard operating procedures.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(88) "https://www.fdanews.com/articles/189873-fda-cites-glaxosmithkline-for-problems-with-sops"
  ["blog_url"]=>
  string(88) "https://www.fdanews.com/articles/189873-fda-cites-glaxosmithkline-for-problems-with-sops"
  [15]=>
  string(19) "2019-01-15 06:59:01"
  ["add_date"]=>
  string(19) "2019-01-15 06:59:01"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:24"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1570"
  ["article_id"]=>
  string(4) "1570"
  [1]=>
  string(85) "Louisiana Seeks Partner for ‘Netflix’ Subscription Model for Hep C Drugs"
  ["article_title"]=>
  string(85) "Louisiana Seeks Partner for ‘Netflix’ Subscription Model for Hep C Drugs"
  [2]=>
  string(158) "&#nl        Louisiana’s Department of Health is seeking a drug manufacturing partner willing to adopt a Netflix-style subscription model for hepatitis "
  ["short_description"]=>
  string(158) "&#nl        Louisiana’s Department of Health is seeking a drug manufacturing partner willing to adopt a Netflix-style subscription model for hepatitis "
  [3]=>
  string(176) "&#nl        Louisiana’s Department of Health is seeking a drug manufacturing partner willing to adopt a Netflix-style subscription model for hepatitis C drugs.&#nl      "
  ["description"]=>
  string(176) "&#nl        Louisiana’s Department of Health is seeking a drug manufacturing partner willing to adopt a Netflix-style subscription model for hepatitis C drugs.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(110) "https://www.fdanews.com/articles/189871-louisiana-seeks-partner-for-netflix-subscription-model-for-hep-c-drugs"
  ["blog_url"]=>
  string(110) "https://www.fdanews.com/articles/189871-louisiana-seeks-partner-for-netflix-subscription-model-for-hep-c-drugs"
  [15]=>
  string(19) "2019-01-15 06:57:17"
  ["add_date"]=>
  string(19) "2019-01-15 06:57:17"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:24"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1657"
  ["article_id"]=>
  string(4) "1657"
  [1]=>
  string(85) "Sound Pharmaceuticals Advances Phase 2 Hearing Loss Clinical Trial in Cystic Fibrosis"
  ["article_title"]=>
  string(85) "Sound Pharmaceuticals Advances Phase 2 Hearing Loss Clinical Trial in Cystic Fibrosis"
  [2]=>
  string(150) "Seattle, WA and Charleston, S.C. -- January 14, 2019 -- Sound Pharmaceuticals (SPI) is pleased to announce that first-patient-in has been achieve"
  ["short_description"]=>
  string(150) "Seattle, WA and Charleston, S.C. -- January 14, 2019 -- Sound Pharmaceuticals (SPI) is pleased to announce that first-patient-in has been achieve"
  [3]=>
  string(251) "Seattle, WA and Charleston, S.C. -- January 14, 2019 -- Sound Pharmaceuticals (SPI) is pleased to announce that first-patient-in has been achieved in the STOP Ototoxicity Phase 2 clinical trial. This novel interventional study with SPI-1005 is..."
  ["description"]=>
  string(251) "Seattle, WA and Charleston, S.C. -- January 14, 2019 -- Sound Pharmaceuticals (SPI) is pleased to announce that first-patient-in has been achieved in the STOP Ototoxicity Phase 2 clinical trial. This novel interventional study with SPI-1005 is..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(260) "https://www.drugs.com/clinical_trials/sound-pharmaceuticals-advances-phase-2-hearing-loss-clinical-trial-cystic-fibrosis-18056.html?utm_source=ddc&utm_medium=rss&utm_campaign=Sound+Pharmaceuticals+Advances+Phase+2+Hearing+Loss+Clinical+Trial+in+Cystic+Fibrosis"
  ["blog_url"]=>
  string(260) "https://www.drugs.com/clinical_trials/sound-pharmaceuticals-advances-phase-2-hearing-loss-clinical-trial-cystic-fibrosis-18056.html?utm_source=ddc&utm_medium=rss&utm_campaign=Sound+Pharmaceuticals+Advances+Phase+2+Hearing+Loss+Clinical+Trial+in+Cystic+Fibrosis"
  [15]=>
  string(19) "2019-01-15 05:01:05"
  ["add_date"]=>
  string(19) "2019-01-15 05:01:05"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:20"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1517"
  ["article_id"]=>
  string(4) "1517"
  [1]=>
  string(63) "U.S. Doctor Released From Omaha Hospital After Ebola Monitoring"
  ["article_title"]=>
  string(63) "U.S. Doctor Released From Omaha Hospital After Ebola Monitoring"
  [2]=>
  string(150) "MONDAY, Jan. 14, 2019 -- An American doctor who was monitored for 21 days after possible Ebola exposure did not develop the deadly disease and has bee"
  ["short_description"]=>
  string(150) "MONDAY, Jan. 14, 2019 -- An American doctor who was monitored for 21 days after possible Ebola exposure did not develop the deadly disease and has bee"
  [3]=>
  string(246) "MONDAY, Jan. 14, 2019 -- An American doctor who was monitored for 21 days after possible Ebola exposure did not develop the deadly disease and has been released from the Nebraska Medicine-Nebraska Medical Center in Omaha, officials say.&#nlThe..."
  ["description"]=>
  string(246) "MONDAY, Jan. 14, 2019 -- An American doctor who was monitored for 21 days after possible Ebola exposure did not develop the deadly disease and has been released from the Nebraska Medicine-Nebraska Medical Center in Omaha, officials say.&#nlThe..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(202) "https://www.drugs.com/news/u-s-doctor-released-omaha-hospital-after-ebola-monitoring-79728.html?utm_source=ddc&utm_medium=rss&utm_campaign=U.S.+Doctor+Released+From+Omaha+Hospital+After+Ebola+Monitoring"
  ["blog_url"]=>
  string(202) "https://www.drugs.com/news/u-s-doctor-released-omaha-hospital-after-ebola-monitoring-79728.html?utm_source=ddc&utm_medium=rss&utm_campaign=U.S.+Doctor+Released+From+Omaha+Hospital+After+Ebola+Monitoring"
  [15]=>
  string(19) "2019-01-15 03:00:18"
  ["add_date"]=>
  string(19) "2019-01-15 03:00:18"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1518"
  ["article_id"]=>
  string(4) "1518"
  [1]=>
  string(58) "800-662-HELP Underappreciated in Media, General Population"
  ["article_title"]=>
  string(58) "800-662-HELP Underappreciated in Media, General Population"
  [2]=>
  string(150) "MONDAY, Jan. 14, 2019 -- The Substance Abuse and Mental Health Services Administration national helpline (800-662-HELP) seems to be underappreciated i"
  ["short_description"]=>
  string(150) "MONDAY, Jan. 14, 2019 -- The Substance Abuse and Mental Health Services Administration national helpline (800-662-HELP) seems to be underappreciated i"
  [3]=>
  string(251) "MONDAY, Jan. 14, 2019 -- The Substance Abuse and Mental Health Services Administration national helpline (800-662-HELP) seems to be underappreciated in the media and by the general population, according to a research letter published online Jan. 14..."
  ["description"]=>
  string(251) "MONDAY, Jan. 14, 2019 -- The Substance Abuse and Mental Health Services Administration national helpline (800-662-HELP) seems to be underappreciated in the media and by the general population, according to a research letter published online Jan. 14..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(196) "https://www.drugs.com/news/800-662-help-underappreciated-media-general-population-79727.html?utm_source=ddc&utm_medium=rss&utm_campaign=800-662-HELP+Underappreciated+in+Media%2C+General+Population"
  ["blog_url"]=>
  string(196) "https://www.drugs.com/news/800-662-help-underappreciated-media-general-population-79727.html?utm_source=ddc&utm_medium=rss&utm_campaign=800-662-HELP+Underappreciated+in+Media%2C+General+Population"
  [15]=>
  string(19) "2019-01-15 03:00:04"
  ["add_date"]=>
  string(19) "2019-01-15 03:00:04"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1541"
  ["article_id"]=>
  string(4) "1541"
  [1]=>
  string(73) "Pharmacy Schools Council expresses concern over GPhC education proposals "
  ["article_title"]=>
  string(73) "Pharmacy Schools Council expresses concern over GPhC education proposals "
  [2]=>
  string(158) "“Appropriate funding” and enhanced quality assurance of preregistration providers is necessary for greater integration between academic study and "
  ["short_description"]=>
  string(158) "“Appropriate funding” and enhanced quality assurance of preregistration providers is necessary for greater integration between academic study and "
  [3]=>
  string(291) "“Appropriate funding” and enhanced quality assurance of preregistration providers is necessary for greater integration between academic study and practical preregistration experience for pharmacists in training to be successful, the Pharmacy Schools Council (PhSC) has warned."
  ["description"]=>
  string(291) "“Appropriate funding” and enhanced quality assurance of preregistration providers is necessary for greater integration between academic study and practical preregistration experience for pharmacists in training to be successful, the Pharmacy Schools Council (PhSC) has warned."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(151) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacy-schools-council-expresses-concern-over-gphc-education-proposals/20205998.article"
  ["blog_url"]=>
  string(151) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacy-schools-council-expresses-concern-over-gphc-education-proposals/20205998.article"
  [15]=>
  string(19) "2019-01-14 23:38:00"
  ["add_date"]=>
  string(19) "2019-01-14 23:38:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:21"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1554"
  ["article_id"]=>
  string(4) "1554"
  [1]=>
  string(50) "A day in the life of an industry marketing manager"
  ["article_title"]=>
  string(50) "A day in the life of an industry marketing manager"
  [2]=>
  string(103) "Pharmacist Chris Maguire details a typical day as a marketing manager for a medical technology company."
  ["short_description"]=>
  string(103) "Pharmacist Chris Maguire details a typical day as a marketing manager for a medical technology company."
  [3]=>
  string(103) "Pharmacist Chris Maguire details a typical day as a marketing manager for a medical technology company."
  ["description"]=>
  string(103) "Pharmacist Chris Maguire details a typical day as a marketing manager for a medical technology company."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(155) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-profile/a-day-in-the-life-of-an-industry-marketing-manager/20205896.article"
  ["blog_url"]=>
  string(155) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-profile/a-day-in-the-life-of-an-industry-marketing-manager/20205896.article"
  [15]=>
  string(19) "2019-01-14 22:52:00"
  ["add_date"]=>
  string(19) "2019-01-14 22:52:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:22"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1501"
  ["article_id"]=>
  string(4) "1501"
  [1]=>
  string(72) "Nature or Nurture? Twins Study Helps Sort Out Genes' Role in Disease"
  ["article_title"]=>
  string(72) "Nature or Nurture? Twins Study Helps Sort Out Genes' Role in Disease"
  [2]=>
  string(154) "MONDAY, Jan. 14, 2019 -- Two of every five common diseases are at least partially influenced by a person's genetics, the largest U.S. study of twins e"
  ["short_description"]=>
  string(154) "MONDAY, Jan. 14, 2019 -- Two of every five common diseases are at least partially influenced by a person's genetics, the largest U.S. study of twins e"
  [3]=>
  string(256) "MONDAY, Jan. 14, 2019 -- Two of every five common diseases are at least partially influenced by a person's genetics, the largest U.S. study of twins ever conducted finds.&#nlNearly 40 percent of 560 different diseases have a genetic component, while..."
  ["description"]=>
  string(256) "MONDAY, Jan. 14, 2019 -- Two of every five common diseases are at least partially influenced by a person's genetics, the largest U.S. study of twins ever conducted finds.&#nlNearly 40 percent of 560 different diseases have a genetic component, while..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(206) "https://www.drugs.com/news/nature-nurture-twins-study-helps-sort-out-genes-role-79720.html?utm_source=ddc&utm_medium=rss&utm_campaign=Nature+or+Nurture%3F+Twins+Study+Helps+Sort+Out+Genes%27+Role+in+Disease"
  ["blog_url"]=>
  string(206) "https://www.drugs.com/news/nature-nurture-twins-study-helps-sort-out-genes-role-79720.html?utm_source=ddc&utm_medium=rss&utm_campaign=Nature+or+Nurture%3F+Twins+Study+Helps+Sort+Out+Genes%27+Role+in+Disease"
  [15]=>
  string(19) "2019-01-14 22:01:07"
  ["add_date"]=>
  string(19) "2019-01-14 22:01:07"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1502"
  ["article_id"]=>
  string(4) "1502"
  [1]=>
  string(64) "Many Teens, Young Adults Don't Get Private Time With Doctors"
  ["article_title"]=>
  string(64) "Many Teens, Young Adults Don't Get Private Time With Doctors"
  [2]=>
  string(150) "MONDAY, Jan. 14, 2019 -- Having confidential talks with a health care provider is important for teens and young adults, but they rarely get the chance"
  ["short_description"]=>
  string(150) "MONDAY, Jan. 14, 2019 -- Having confidential talks with a health care provider is important for teens and young adults, but they rarely get the chance"
  [3]=>
  string(257) "MONDAY, Jan. 14, 2019 -- Having confidential talks with a health care provider is important for teens and young adults, but they rarely get the chance to do so, a new study finds.&#nl"Discussing confidentiality and having private time with a provider..."
  ["description"]=>
  string(257) "MONDAY, Jan. 14, 2019 -- Having confidential talks with a health care provider is important for teens and young adults, but they rarely get the chance to do so, a new study finds.&#nl"Discussing confidentiality and having private time with a provider..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(196) "https://www.drugs.com/news/many-teens-young-adults-don-t-private-time-doctors-79708.html?utm_source=ddc&utm_medium=rss&utm_campaign=Many+Teens%2C+Young+Adults+Don%27t+Get+Private+Time+With+Doctors"
  ["blog_url"]=>
  string(196) "https://www.drugs.com/news/many-teens-young-adults-don-t-private-time-doctors-79708.html?utm_source=ddc&utm_medium=rss&utm_campaign=Many+Teens%2C+Young+Adults+Don%27t+Get+Private+Time+With+Doctors"
  [15]=>
  string(19) "2019-01-14 20:01:07"
  ["add_date"]=>
  string(19) "2019-01-14 20:01:07"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1519"
  ["article_id"]=>
  string(4) "1519"
  [1]=>
  string(58) "Lack of Parent-Teen Agreement About Teen Suicidal Thoughts"
  ["article_title"]=>
  string(58) "Lack of Parent-Teen Agreement About Teen Suicidal Thoughts"
  [2]=>
  string(150) "MONDAY, Jan. 14, 2019 -- There is a high prevalence of parental unawareness and adolescent denial of suicidal thoughts, according to a study published"
  ["short_description"]=>
  string(150) "MONDAY, Jan. 14, 2019 -- There is a high prevalence of parental unawareness and adolescent denial of suicidal thoughts, according to a study published"
  [3]=>
  string(259) "MONDAY, Jan. 14, 2019 -- There is a high prevalence of parental unawareness and adolescent denial of suicidal thoughts, according to a study published online Jan. 14 in Pediatrics.&#nlJason D. Jones, Ph.D., from the Children's Hospital of Philadelphia,..."
  ["description"]=>
  string(259) "MONDAY, Jan. 14, 2019 -- There is a high prevalence of parental unawareness and adolescent denial of suicidal thoughts, according to a study published online Jan. 14 in Pediatrics.&#nlJason D. Jones, Ph.D., from the Children's Hospital of Philadelphia,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(189) "https://www.drugs.com/news/lack-parent-teen-agreement-teen-suicidal-thoughts-79711.html?utm_source=ddc&utm_medium=rss&utm_campaign=Lack+of+Parent-Teen+Agreement+About+Teen+Suicidal+Thoughts"
  ["blog_url"]=>
  string(189) "https://www.drugs.com/news/lack-parent-teen-agreement-teen-suicidal-thoughts-79711.html?utm_source=ddc&utm_medium=rss&utm_campaign=Lack+of+Parent-Teen+Agreement+About+Teen+Suicidal+Thoughts"
  [15]=>
  string(19) "2019-01-14 20:00:51"
  ["add_date"]=>
  string(19) "2019-01-14 20:00:51"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:20"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:20"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}